18.26 USD
↗ 0.23 (1.30%)PRE MARKET (AS OF 08:54 AM EDT)
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTXNASDAQ • USD
Market: OPEN
MLTX is currently priced at $18.26. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place MLTX at a fair price relative to peers.
Technical & fundamental data as of Aug 6, 2026.
Open?$18.45
High?$18.45
Low?$18.25
Prev. Close?$18.03
Volume?1.7K
Avg. Volume?1.1M
VWAP?$18.28
Rel. Volume?0.00x
Bid / Ask
Bid?$15.41 × 100
Ask?$21.24 × 100
Spread?$5.83
Midpoint?$18.33
Valuation & Ratios
Market Cap?1.5B
Shares Out?73.6M
Float?61.4M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?6.04
EPS?-$3.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Employees
130
Market Cap
1.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-04-06
Address
DORFSTRASSE 29
ZUG, V8 6300
Phone: 41 41 510 8022
ZUG, V8 6300
Phone: 41 41 510 8022
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?79
Momentum?23
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?3.27Safe
Confidence?46%Low
Short InterestHigh
Short % of Float?10.32%High
Short Interest?6.3M
Days to Cover?5.0
Free Float61.4M
Avg Daily Volume1.3M
Settlement Date2026-07-15
Financial Health
Current Ratio?8.60Strong
Quick Ratio?8.60Strong
Cash Ratio?6.47Strong
Debt/Equity?0.39Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.04FAIR▾
Peers100
S&P30
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-100.6%WEAK▾
S&P3
ROA?-63.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-224153000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day